Sorry, you need to enable JavaScript to visit this website.

Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee

A Phase 3 Randomized, Double-Blind, Placebo Multicenter Study of the Analgesic Efficacy and Safety of A
Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Category & Conditions: Immune System Diseases and Conditions
Medicine: tanezumab Identifier (NCT): NCT02697773
Protocol ID: A4091056
Open Plain Language Summary Result: Click here